Woolsey Pharmaceuticals
PrivateLast Round
Series B
Extension
Feb 27, 2025
Total Funding Raised
$19.7M
Company Overview
Woolsey Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on developing and repurposing therapeutics for the treatment of neurodegenerative diseases such as ALS.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Woolsey Pharmaceuticals Comparables
Compare Woolsey Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Graviton BioScience | 84% | |
| QurAlis | 80% | |
| NeuroSense Therapeutics | 79% |
Woolsey Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 27, 2025 | ||||
| Series B | Oct 1, 2021 | ||||
| VC Round | Mar 11, 2020 |
Woolsey Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rapaski Capital Group | Series B Extension, Series B |
| Nelstone Ventures | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 77% MoM, reaching 1.9K.
- Feb 27, 2025
Raised capital from Nelstone Ventures and Rapaski Capital Group.
Woolsey Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Woolsey Pharmaceuticals's valuation, stock price, and market status.
Is Woolsey Pharmaceuticals a public or private company?
Woolsey Pharmaceuticals is a private company.
What is the current stock price of Woolsey Pharmaceuticals?
Woolsey Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Woolsey Pharmaceuticals worth (valuation)?
Valuation information for Woolsey Pharmaceuticals is not publicly available.
Can I buy Woolsey Pharmaceuticals stock?
Woolsey Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Woolsey Pharmaceuticals's last funding round?
Woolsey Pharmaceuticals's most recent funding round was Series B Extension on February 27, 2025.
Who are the main investors in Woolsey Pharmaceuticals?
Key investors in Woolsey Pharmaceuticals include Rapaski Capital Group, Nelstone Ventures.
Will Woolsey Pharmaceuticals IPO soon?
No public IPO plans have been announced for Woolsey Pharmaceuticals.
How can I track Woolsey Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Woolsey Pharmaceuticals's secondary market activity and sign up for updates.